Treatment: the Journey Between Patient and DoctorBy Miriam Bello | Fri, 01/29/2021 - 13:42
Q: What are the main challenges to quickly and safely integrating digitalization into healthcare?
A: Much has already been said about how the pandemic has accelerated digitalization in all industries. In the health sector, there have been countless forums that have talked about the importance of telemedicine, for example. Unfortunately, the grassroots of the health sector in Mexico will not allow for an easy transformation. In some cases, the telemedicine solution might even go against the business models of many health providers. It is complicated to adapt telemedicine in this scenario.
There is still much that needs to be regulated so there is less resistance among people. A suitable business model has not yet been created where digital solutions become a necessity. On the contrary, many technologies are being implemented for business models that are not sustainable in the long term. That is why they are not used or end up being outdated.
Q: How has Apolo Health adapted to the needs of health providers to build an effective platform for patient relationship management?
A: We have been learning alongside the health system for a long time. We have always been aware of the need to create small health ecosystems where a patient can find the different solutions they need under one service channel. One of the big problems in the health sector in Mexico is individualism and the lack of communication between industry actors. We have seen how patients stop being people to become users. To change this, a new business and financing model is needed. We have studied different health systems in other countries, such as Colombia and Argentina, and know that there are solutions in areas that are completely neglected in Mexico.
Apolo Health is a company that creates solutions to improve the relationship between providers and patients through different communication channels. It uses data generated on its platform to benefit the patient. This data includes clinical history, which allows us to offer new health services to patients with diabetes or hypertension.
We have realized that this change is not easy for healthcare providers because they are focused on their core business. In 2021, we have set out to create health programs supported by smart medical devices for the treatment of chronic diseases like diabetes.
Q: How do your solutions complement each other and create a functional environment for healthcare providers and patients?
A: Through our platforms, we understand the needs and target market of each of our clients when building different communication channels. For example, if our client is a group of pediatricians, the target market is parents. In the health journey, it is very easy to lose a patient to another health provider. Through alliances and strategies, we try to ensure that this does not happen and that patients become loyal customers. The pandemic highlighted the lack of communication between doctors and their patients. When a person gets sick, they usually do not know to whom or where to go. Apolo wants to change that.
Q: What are Apolo Health’s growth and expansion plans?
A: We have two projects in progress. The first focuses on the management and administration of chronic diseases. We will start with diabetes and then include patients with hypertension, gradually adding other conditions like obesity. We will first identify the population with a predisposition or already suffering from diabetes and we will offer them a subscription service. They will receive the necessary devices and access to our application, among other tools. We are also developing a service to provide financial solutions for healthcare. We want to offer accessible solutions to help specific sectors of the population.
Apolo Health is a digital integrator of health services for hospitals. It offers two main services: Apolo Intel, which provides advisory services, and Apolo Engagement, which allows healthcare providers to create and build relationships with patients.